Syk: a new player in the field of breast cancer

Por Stewart, Zoe A, Pietenpol, Jennifer A
Publicado em 2001

mTOR regulates autophagy-associated genes downstream of p73

Por Rosenbluth, Jennifer M., Pietenpol, Jennifer A.
Publicado em 2009

Identification and use of biomarkers in treatment strategies for triple negative breast cancer subtypes

Por Lehmann, Brian D., Pietenpol, Jennifer A.
Publicado em 2014

Clinical implications of molecular heterogeneity in triple negative breast cancer

Por Lehmann, Brian D., Pietenpol, Jennifer A.
Publicado no Breast (2015)

Kinetics of p53 Binding to Promoter Sites In Vivo

Por Szak, Suzanne T., Mays, Deborah, Pietenpol, Jennifer A.
Publicado em 2001

p21(Waf1/Cip1) Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption

Por Stewart, Zoe A., Leach, Steven D., Pietenpol, Jennifer A.
Publicado em 1999

Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives

Por Ye, Fei, Bauer, Joshua A, Pietenpol, Jennifer A, Shyr, Yu
Publicado em 2012

The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations

Por Westfall, Matthew D., Mays, Deborah J., Sniezek, Joseph C., Pietenpol, Jennifer A.
Publicado em 2003

Patient-derived breast tumor xenografts facilitating personalized cancer therapy

Por Landis, Melissa D, Lehmann, Brian D, Pietenpol, Jennifer A, Chang, Jenny C
Publicado em 2013

NEW STRATEGIES FOR TRIPLE NEGATIVE BREAST CANCER – DECIPHERING THE HETEROGENEITY

Por Mayer, Ingrid A., Abramson, Vandana G., Lehmann, Brian D., Pietenpol, Jennifer A.
Publicado em 2014

Subtyping of triple-negative breast cancer: implications for therapy

Por Abramson, Vandana G., Lehmann, Brian D., Ballinger, Tarah J., Pietenpol, Jennifer A.
Publicado no Cancer (2014)

Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis

Por Rosenbluth, Jennifer M., Mays, Deborah J., Jiang, Aixiang, Shyr, Yu, Pietenpol, Jennifer A.
Publicado em 2011

p53 Regulation of G(2) Checkpoint Is Retinoblastoma Protein Dependent

Por Flatt, Patricia M., Tang, Luo Jia, Scatena, Caroline D., Szak, Suzanne T., Pietenpol, Jennifer A.
Publicado em 2000

K-Ras-Independent Effects of the Farnesyl Transferase Inhibitor L-744,832 on Cyclin B1/Cdc2 Kinase Activity, G2/M Cell Cycle Progression and Apoptosis in Human Pancreatic Ductal Ad...

Por Song, Si Young, Meszoely, Ingrid M, Coffey, Robert J, Pietenpol, Jennifer A, Leach, Steven D
Publicado em 2000

A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73

Por Rosenbluth, Jennifer M., Mays, Deborah J., Pino, Maria F., Tang, Luo Jia, Pietenpol, Jennifer A.
Publicado em 2008

Chromatin Immunoprecipitation-Based Screen To Identify Functional Genomic Binding Sites for Sequence-Specific Transactivators

Por Hearnes, Jamie M., Mays, Deborah J., Schavolt, Kristy L., Tang, Luojia, Jiang, Xin, Pietenpol, Jennifer A.
Publicado em 2005

The DNA Binding Activity of p53 Displays Reaction-Diffusion Kinetics

Por Hinow, Peter, Rogers, Carl E., Barbieri, Christopher E., Pietenpol, Jennifer A., Kenworthy, Anne K., DiBenedetto, Emmanuele
Publicado em 2006

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Por Chen, Xi, Li, Jiang, Gray, William H., Lehmann, Brian D., Bauer, Joshua A., Shyr, Yu, Pietenpol, Jennifer A.
Publicado em 2012

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Por Lehmann, Brian D., Bauer, Joshua A., Chen, Xi, Sanders, Melinda E., Chakravarthy, A. Bapsi, Shyr, Yu, Pietenpol, Jennifer A.
Publicado em 2011

Detection of internal exon deletion with exon Del

Por Guo, Yan, Zhao, Shilin, Lehmann, Brian D, Sheng, Quanhu, Shaver, Timothy M, Stricker, Thomas P, Pietenpol, Jennifer A, Shyr, Yu
Publicado no BMC Bioinformatics (2014)